These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 402750)

  • 1. Influence of anti-rheumatic drugs on human lymphocytes in vitro.
    Yoshino S; Ishiyama I
    Z Rheumatol; 1977; 36(1-2):28-35. PubMed ID: 402750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. On the effects of antirheumatic drugs on protein sulphydryl reactivity in human serum.
    Pickup ME; Dixon JS; Bird HA
    J Pharm Pharmacol; 1980 Apr; 32(4):301-2. PubMed ID: 6103066
    [No Abstract]   [Full Text] [Related]  

  • 3. In vitro and in vivo inhibition of activation induced T cell apoptosis by bucillamine.
    Okazaki H; Sato H; Kamimura T; Hirata D; Iwamoto M; Yoshio T; Mimori A; Masuyama JI; Kano S; Minota S
    J Rheumatol; 2000 Jun; 27(6):1358-64. PubMed ID: 10852254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of some anti-rheumatic agents on copper-catalyzed thermal aggregation of gamma globulin.
    Kuzuna S; Morimoto S; Kawai K
    Agents Actions; 1979 Oct; 9(4):375-80. PubMed ID: 92884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The action of D-penicillamine on the distribution of T and B-lymphocytes in rheumatoid arthritis].
    Crouzet J; Fournier C; Bach JF; Camus JP
    Rev Rhum Mal Osteoartic; 1977 May; 44(5):335-7. PubMed ID: 329400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of Cuprenil (penicillamine) on peripheral blood lymphocytes and their T and B populations in patients with rheumatoid arthritis].
    Małdykowa H; Brühl W; Chwalińska-Sadowska H; Grabowska A; Cygler B; Dratwianka B; Abgarowicz T; Wierzchowska E
    Reumatologia; 1978; 16(4):509-13. PubMed ID: 310147
    [No Abstract]   [Full Text] [Related]  

  • 7. The effects of antirheumatic drugs on the production of collagenase and tissue inhibitor of metalloproteinases (TIMP) by stimulated rabbit articular chrondrocytes.
    Hunter T; Duncan S; Dew G; Reynolds JJ
    J Rheumatol; 1984 Feb; 11(1):9-13. PubMed ID: 6321725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism of action of the disease-modifying anti-arthritic thiol agents D-penicillamine and sodium aurothiomalate: restoration of cellular free thiols and sequestration of reactive aldehydes.
    Wood PL; Khan MA; Moskal JR
    Eur J Pharmacol; 2008 Feb; 580(1-2):48-54. PubMed ID: 18022616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of patients with rheumatoid arthritis with DMARD (disease modifying anti-rheumatic drugs)].
    Halberg P
    Ugeskr Laeger; 1984 Jul; 146(27):1995-2000. PubMed ID: 6440327
    [No Abstract]   [Full Text] [Related]  

  • 10. Disease-modifying agents in rheumatoid arthritis.
    Lipsky PE
    Ryumachi; 1987 Dec; 27(6):409-12. PubMed ID: 2455354
    [No Abstract]   [Full Text] [Related]  

  • 11. B lymphocyte function in patients with rheumatoid arthritis: impact of regulatory T lymphocytes and macrophages--modulation by antirheumatic drugs.
    Petersen J
    Dan Med Bull; 1988 Apr; 35(2):140-57. PubMed ID: 3282810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Inhibition of leukocyte collagenase and cathepsin G by anti-rheumatic drugs].
    Stancíková M; Trnavský K
    Fysiatr Revmatol Vestn; 1980 Aug; 58(4):189-92. PubMed ID: 6158471
    [No Abstract]   [Full Text] [Related]  

  • 13. Disease-modifying drugs for progressive rheumatoid arthritis.
    Bunch TW; O'Duffy JD
    Mayo Clin Proc; 1980 Mar; 55(3):161-79. PubMed ID: 6766523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunosuppressive actions of gold salts.
    Petersen J; Bendtzen K
    Scand J Rheumatol Suppl; 1983; 51():28-35. PubMed ID: 6426050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A study of the influence of various antirheumatic drug regimens on serum acute-phase proteins, plasma tryptophan, and erythrocyte sedimentation rate in rheumatoid arthritis.
    Aylward M; Maddock J; Wheeldon R; Parker RJ
    Rheumatol Rehabil; 1975 May; 14(2):101-14. PubMed ID: 238274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduction of peripheral blood lymphocytes in patients receiving gold therapy for rheumatoid arthritis.
    Hanly JG; Bresnihan B
    Ann Rheum Dis; 1985 May; 44(5):299-301. PubMed ID: 3923951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of antirheumatic drugs on protein sulphydryl reactivity of human serum.
    Hall NC; Gillan AH
    J Pharm Pharmacol; 1979 Oct; 31(10):676-80. PubMed ID: 41040
    [No Abstract]   [Full Text] [Related]  

  • 18. Slow acting anti-rheumatic drugs in the treatment of rheumatoid arthritis.
    Kovarsky J
    Tex Med; 1985 Sep; 81(9):35-9. PubMed ID: 3931276
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of anti-rheumatic drugs on PHA-stimulated lymphocytes and established cell lines.
    Miyazawa T; Umeda M; Okamoto R; Tsuchiya K
    Ryumachi; 1976 May; 16(2):191-7. PubMed ID: 822519
    [No Abstract]   [Full Text] [Related]  

  • 20. Slow onset anti-rheumatic drugs in rheumatoid arthritis: could the presence of antinuclear antibody influence the therapeutic results?
    Menard HA; Mathieu JP; de Medicis R; Lussier A
    J Rheumatol; 1979; 6(2):156-62. PubMed ID: 110929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.